Weijing Yang

4.9k total citations · 1 hit paper
69 papers, 4.1k citations indexed

About

Weijing Yang is a scholar working on Biomedical Engineering, Molecular Biology and Biomaterials. According to data from OpenAlex, Weijing Yang has authored 69 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Biomedical Engineering, 28 papers in Molecular Biology and 23 papers in Biomaterials. Recurrent topics in Weijing Yang's work include Nanoplatforms for cancer theranostics (32 papers), Nanoparticle-Based Drug Delivery (23 papers) and RNA Interference and Gene Delivery (14 papers). Weijing Yang is often cited by papers focused on Nanoplatforms for cancer theranostics (32 papers), Nanoparticle-Based Drug Delivery (23 papers) and RNA Interference and Gene Delivery (14 papers). Weijing Yang collaborates with scholars based in China, United States and Singapore. Weijing Yang's co-authors include Hongzhang Deng, Lisen Lin, Zhiyuan Zhong, Fenghua Meng, Sheng Wang, Xiaohong Chen, Zijian Zhou, Xiaoyuan Chen, Guocan Yu and Zhantong Wang and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Angewandte Chemie International Edition.

In The Last Decade

Weijing Yang

67 papers receiving 4.1k citations

Hit Papers

Endoplasmic Reticulum Targeting to Amplify Immunogenic Ce... 2020 2026 2022 2024 2020 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Endoplasmic Reticulum Targeting to Amplify Immunogenic Cell Death for Cancer Immunotherapy
    2020 313 citations Hongzhang Deng, Zijian Zhou et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weijing Yang China 37 2.5k 1.4k 1.3k 995 792 69 4.1k
Jinrong Peng China 39 3.0k 1.2× 1.1k 0.8× 1.9k 1.4× 982 1.0× 563 0.7× 93 4.6k
Xiaopin Duan China 24 3.1k 1.3× 1.3k 0.9× 1.5k 1.2× 1.3k 1.3× 1.1k 1.4× 44 5.0k
Kun Shao China 36 3.0k 1.2× 2.1k 1.5× 1.2k 0.9× 1.5k 1.5× 638 0.8× 75 5.3k
Sejin Son South Korea 31 2.4k 1.0× 1.8k 1.3× 1.3k 1.0× 702 0.7× 1.0k 1.3× 51 4.3k
Dangge Wang China 31 3.4k 1.3× 1.5k 1.1× 1.6k 1.3× 928 0.9× 1.5k 1.9× 53 4.9k
Yiye Li China 30 2.3k 0.9× 1.4k 1.0× 1.3k 1.0× 1.6k 1.6× 455 0.6× 50 4.3k
Chenggen Qian China 32 2.1k 0.8× 1.1k 0.8× 1.0k 0.8× 1.1k 1.1× 332 0.4× 54 3.6k
Yuanzeng Min China 28 2.0k 0.8× 1.3k 0.9× 1.5k 1.1× 1.1k 1.1× 588 0.7× 61 4.0k
Xuexiang Han China 42 2.1k 0.8× 2.6k 1.9× 1.2k 0.9× 1.0k 1.0× 840 1.1× 64 5.4k
Xinyu He China 23 2.0k 0.8× 1.1k 0.8× 1.3k 1.0× 643 0.6× 453 0.6× 64 3.2k

Countries citing papers authored by Weijing Yang

Since Specialization
Citations

This map shows the geographic impact of Weijing Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijing Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijing Yang more than expected).

Fields of papers citing papers by Weijing Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weijing Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijing Yang. The network helps show where Weijing Yang may publish in the future.

Co-authorship network of co-authors of Weijing Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Weijing Yang. A scholar is included among the top collaborators of Weijing Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weijing Yang. Weijing Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Tian, et al.. (2025). ZYG11B suppresses multiple enteroviruses by triggering viral VP1 degradation. Journal of Virology. 99(4). e0003025–e0003025. 2 indexed citations
2.
Zhang, Jinjie, Jieke Zhang, Shuo Zhang, et al.. (2025). Dual-barrier traversing liposomes with ROS-responsive rigidity tuning for oral ischemic stroke therapy. Journal of Controlled Release. 385. 113955–113955.
3.
Yang, Weijing, et al.. (2025). FBXO45 restricts HIV-1 replication by inducing SQSTM1/p62-mediated autophagic degradation of Tat. Journal of Virology. 99(3). e0191224–e0191224.
4.
Li, Ning, et al.. (2025). Cu( ii )-catalyzed asymmetric Mukaiyama–Michael reaction: concise synthesis of cyclohexadiene analogues. Organic Chemistry Frontiers. 12(10). 3271–3278. 2 indexed citations
5.
Chen, Junjian, Chen Huan, Baisong Zheng, et al.. (2025). A novel FITC.Chimeric antigen receptor-T cell targeting HIV-1-infected cells with FITC-conjugated antibodies for enhanced cytotoxicity. International Journal of Biological Macromolecules. 319(Pt 4). 145715–145715. 1 indexed citations
6.
Yang, Weijing, Yan Wang, Yong Fu, et al.. (2025). Correlation between Castelli risk index-I and female infertility: A cross-sectional study. Lipids in Health and Disease. 24(1). 200–200. 1 indexed citations
7.
Li, Yongjuan, Yayun Wang, Xiaohan Lou, et al.. (2024). A polymeric nanoplatform enhances the cGAS-STING pathway in macrophages to potentiate phagocytosis for cancer immunotherapy. Journal of Controlled Release. 373. 447–462. 14 indexed citations
8.
Li, Yongjuan, Rongrong Zhu, Yichen Guo, et al.. (2024). Sequential-gated transformable nanoprodrug potentiates antitumor immunity through TME modulation and STING activation. Chinese Chemical Letters. 36(9). 110704–110704. 2 indexed citations
9.
Yang, Weijing, et al.. (2024). RPLP1 restricts HIV-1 transcription by disrupting C/EBPβ binding to the LTR. Nature Communications. 15(1). 5290–5290. 3 indexed citations
10.
Li, Yongjuan, Mengzhe Zhang, Rong Ma, et al.. (2024). Polymeric nanocarrier via metabolism regulation mediates immunogenic cell death with spatiotemporal orchestration for cancer immunotherapy. Nature Communications. 15(1). 8586–8586. 31 indexed citations
11.
Guo, Yichen, et al.. (2023). Nanotechnology-Assisted Immunogenic Cell Death for Effective Cancer Immunotherapy. Vaccines. 11(9). 1440–1440. 3 indexed citations
12.
Li, Yongjuan, et al.. (2023). Cell Death Pathway Regulation by Functional Nanomedicines for Robust Antitumor Immunity. Advanced Science. 11(3). e2306580–e2306580. 35 indexed citations
13.
Ma, Xiaohong, et al.. (2023). Recent Progress in Multiple Sclerosis Treatment Using Immune Cells as Targets. Pharmaceutics. 15(3). 728–728. 9 indexed citations
14.
Zhou, Zijian, Hongzhang Deng, Weijing Yang, et al.. (2020). Early stratification of radiotherapy response by activatable inflammation magnetic resonance imaging. Nature Communications. 11(1). 3032–3032. 77 indexed citations
15.
Deng, Hongzhang, Weijing Yang, Zijian Zhou, et al.. (2020). Targeted scavenging of extracellular ROS relieves suppressive immunogenic cell death. Nature Communications. 11(1). 4951–4951. 202 indexed citations
16.
Liu, Dahai, Zijian Zhou, Xinyu Wang, et al.. (2020). Yolk-shell nanovesicles endow glutathione-responsive concurrent drug release and T1 MRI activation for cancer theranostics. Biomaterials. 244. 119979–119979. 39 indexed citations
17.
Yang, Weijing, Yaohua Wei, Liang Yang, et al.. (2018). Granzyme B-loaded, cell-selective penetrating and reduction-responsive polymersomes effectively inhibit progression of orthotopic human lung tumor in vivo. Journal of Controlled Release. 290. 141–149. 53 indexed citations
18.
Fang, Yuan, Weijing Yang, Liang Cheng, et al.. (2017). EGFR-targeted multifunctional polymersomal doxorubicin induces selective and potent suppression of orthotopic human liver cancer in vivo. Acta Biomaterialia. 64. 323–333. 64 indexed citations
19.
Li, Xiang, Weijing Yang, Yan Zou, et al.. (2015). Efficacious delivery of protein drugs to prostate cancer cells by PSMA-targeted pH-responsive chimaeric polymersomes. Journal of Controlled Release. 220(Pt B). 704–714. 67 indexed citations
20.
Zou, Yan, Weijing Yang, Fenghua Meng, & Zhiyuan Zhong. (2015). Targeted hepatoma chemotherapy in vivo using galactose-decorated crosslinked pH-sensitive degradable micelles. Journal of Controlled Release. 213. e125–e126. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinrong Peng Breakdown of academic impact, for papers by Xiaopin Duan Breakdown of academic impact, for papers by Kun Shao Breakdown of academic impact, for papers by Sejin Son Breakdown of academic impact, for papers by Dangge Wang Breakdown of academic impact, for papers by Yiye Li Breakdown of academic impact, for papers by Chenggen Qian Breakdown of academic impact, for papers by Yuanzeng Min Breakdown of academic impact, for papers by Xuexiang Han Breakdown of academic impact, for papers by Xinyu He
Rankless by CCL
2026